CompoAtlas

Memoptic

Food supplement declared in France, declaration No 2022-7-85

Memoptic is a food supplement declared in France. Status: retiré du marché le 5 September 2026. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
Laboratoire Densmore Belgium
Status
Retiré du marché le 5 September 2026
Form
Gélule
Daily dose
2 comprimés
Directions for use
1 à 2 comprimés par jour à avaler au cours d'un repas, pendant 3 à 6 mois renouvelable
Intended populations
Adolescents de 11 à 17 ans, Personnes de plus de 60 ans, Homme, Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous antidépresseurs
Objectives stated by the manufacturer (these are not authorised claims)
Mémoire, Œil / Vision

Declaration 305068, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Ginkgo biloba L.FeuilleExtrait sec hydroalcoolique80 mg

Other active ingredients

NamePer day
Citicolinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothénate de calciumAcide pantothénique (vitamine B5)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Oxyde de magnésiumMagnésium250 mg300 mg
Bisglycinate de zincZinc25 mg15 mg

Additives

Hydroxypropyl Méthyl Cellulose, E470b

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Demandez conseil à votre médecin en cas de prise simultanée d'anticoagulants.Déconseillé aux femmes enceintes, allaitantes et aux personnes sous traitement antidépresseur.Usage déconseillé aux enfants.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line